AS
ORMP icon

Altshuler Shaham’s Oramed Pharmaceuticals ORMP Stock Holding History

Altshuler Shaham’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.9K Hold
11,211
– – ﹤0.01% 226
2026
Q1 		$38.1K Hold
11,211
– – ﹤0.01% 193
2025
Q4 		$32K Hold
11,211
– – ﹤0.01% 185
2025
Q3 		$29.6K Sell
11,211
-643
-5% -$1.42K ﹤0.01% 165
2025
Q2 		$26.6K Hold
11,854
– – ﹤0.01% 169
2025
Q1 		$25.4K Hold
11,854
– – ﹤0.01% 155
2024
Q4 		$28.6K Sell
11,854
-166
-1% -$394 ﹤0.01% 160
2024
Q3 		$29.4K Hold
12,020
– – ﹤0.01% 108
2024
Q2 		$30.9K Hold
12,020
– – ﹤0.01% 114
2024
Q1 		$35.1K Sell
12,020
-827
-6% -$2.31K ﹤0.01% 113
2023
Q4 		$29.6K Hold
12,847
– – ﹤0.01% 146
2023
Q3 		$33.4K Hold
12,847
– – ﹤0.01% 163
2023
Q2 		$46.1K Hold
12,847
– – ﹤0.01% 171
2023
Q1 		$28K Hold
12,847
– – ﹤0.01% 294
2022
Q4 		$153K Buy
+12,847
New +$99.9K 0.01% 106

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Altshuler Shaham's ORMP Position: Q2 2026 in Review

Altshuler Shaham held its Oramed Pharmaceuticals (ORMP) position steady in Q2 2026 at 11,211 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #226.

Altshuler Shaham first reported a position in ORMP in Q4 2022 and has held it in 15 quarters since. The position peaked at $153K in Q4 2022. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Altshuler Shaham held 11,211 shares of Oramed Pharmaceuticals worth $53.9K as of Q2 2026.
  • Altshuler Shaham left its Oramed Pharmaceuticals share count unchanged in Q2 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #226 holding.
  • Altshuler Shaham first reported a position in Oramed Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Altshuler Shaham's Oramed Pharmaceuticals position peaked at $153K in Q4 2022.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.